/content/dam/www/people-profile-photos/c/john-colgan/john-colgan-d.jpg
/content/dam/www/people-profile-photos/c/john-colgan/provider-john-colgan-directory-2x.jpg
Colgan
John N. Colgan, MD, DCH
- Assistant Professor, Clinical Research Division, Fred Hutch
- Assistant Professor, Department of Pediatrics, University of Washington
- Attending Physician, Pediatric Blood and Marrow Transplant Program, Seattle Children's Hospital
Background
Dr. John Colgan is a clinician-researcher focusing on leukemia biology, precision-guided therapies, and umbilical cord blood transplantation. Dr. Colgan has clinical expertise in hematopoietic stem cell transplantation for lymphoma and high-risk leukemia, including acute lymphoblastic leukemia and acute myeloid leukemia. He is board-certified in medical oncology by the Royal Australian College of Physicians.
Education
Pediatric Bone Marrow Transplantation & Immunotherapy Fellowship, Fred Hutch Cancer Center/Seattle Children’s Hospital, 2025
Pediatric Oncology, Hematology & BMT Fellowship, Sydney Children's Hospital, 2024
Pediatric Residency, Sydney Children's Hospital, 2021
MD, University of New South Wales, 2016
BMed (Bachelor of Medicine), University of New South Wales, 2016
Board Certifications
Medical Oncology, Royal Australian College of Physicians (RACP), 2024
Research Focus
Leukemia biology
Functional genomics in leukemia
Precision guided therapies
Umbilical cord blood transplantation
Clinical Expertise
Hematopoietic stem cell transplantation
High risk leukemia